+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 10Years - 90Years
All Genders
ID07841470

Randomized Comparison of Pulsed vs. Non-pulsed Corneal Crosslinking for Progressive Keratoconus or Ectasia

Led by Price Vision Group · Updated on 2026-09-25

500

Participants Needed

1

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

This study evaluates two different corneal crosslinking treatments for people diagnosed with keratoconus or corneal ectasia, conditions that affect the cornea of the eye. The trial is randomized and compares the effects of pulsed versus non-pulsed ultraviolet A light exposure during treatment. It aims to determine which method better improves corneal shape and vision over time. Participants receive treatment with 0.1% riboflavin eye drops combined with ultraviolet A light. One group receives pulsed 18 milliwattcm2 light for 10 minutes, while the other group receives non-pulsed 9 milliwattcm2 light for 10 minutes. The treatments are designed to strengthen the cornea and are directly compared in this study. Throughout the study, participants undergo assessments including measurements of the maximum curvature of the cornea keratometry and both corrected and uncorrected distance vision at 6 months after treatment. These evaluations help researchers understand changes in eye structure and visual acuity. The study includes regular monitoring and follows participants until the primary outcome is measured at 6 months post-treatment.

CONDITIONS

Brief Title

Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia

Research Team

M

Marianne Price, PhD

F

Francis Price, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here